An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

Keyphrases

• Pharmacology 100%
• Receptor Activity-modifying Protein 100%
• Calcitonin Receptor 76%
• G Protein-coupled Receptor 46%
• Calcitonin Gene-related Peptide 15%
• Amylin 15%
• Agonist Binding 7%
• Protein Complex 7%
• Calcitonin 7%
• Conformational Change 7%
• Functional Assay 7%
• Molecular Modeling 7%
• Prototypic 7%
• Extracellular Domain 7%
• Cellular Response 7%
• Mutagenesis 7%
• N-terminal Domain 7%
• Peptide Interaction 7%
• Molecular Dynamics Simulation 7%
• Protein-protein Interaction 7%
• Conformational States 7%
• G Protein Signaling 7%
• Receptor Conformation 7%
• Regulatory Proteins 7%
• Protein-receptor Interaction 7%
• External Signal 7%
• Molecular Insight 7%
• Control Transmission 7%
• Ligand Binding Assay 7%
• Ligand Specificity 7%
• Ligand Preference 7%
• Allosteric Enzyme 7%

Biochemistry, Genetics and Molecular Biology

• G Protein Coupled Receptor 100%
• Receptor Activity-Modifying Protein 100%
• Calcitonin Receptor 83%
• Calcitonin Gene-Related Peptide 16%
• Amylin 16%
• Agonist 8%
• Protein Complexes 8%
• Ligand Binding 8%
• N-Terminus 8%
• Conformation 8%
• Conformational Change 8%
• Molecular Model 8%
• RAMP1 8%
• Mutagenesis 8%
• Protein Interaction 8%
• Signaling Protein 8%
• Computer Simulation 8%
• Calcitonin 8%
• G Protein 8%

Pharmacology, Toxicology and Pharmaceutical Science

• G Protein Coupled Receptor 100%
• Receptor Activity Modifying Protein 100%
• Calcitonin Receptor 83%
• Receptor 41%
• Calcitonin Gene Related Peptide 16%
• Amylin 16%
• Calcitonin 8%
• Receptor Activity Modifying Protein 1 8%
• Receptor Protein 8%
• Guanine Nucleotide Binding Protein 8%
• Mutagenesis 8%
• Regulator Protein 8%